ERK

You have access
Methoxy and Ketone Substitutions of Resveratrol Enhance Its Anticancer Activity by Increasing MEK and ERK Binding Affinity in Colorectal Cancer Cells
PATTHARAPORN SAELIM, ZIN ZIN EI, SATAPAT RACHA, MASASHI YOKOYA, RIKAKO YAMASHITA, PREEDAKORN CHUNHACHA and PITHI CHANVORACHOTE

Anticancer Research April 2026, 46 (4) 1957-1966; DOI: https://doi.org/10.21873/anticanres.18087
You have access
Lenvatinib Exhibits Potent Anti-tumor Activity and Favorable Safety Profile in a Colorectal Cancer Xenograft Model
CHEN-YU KUO, TSAI-LAN LIAO, FEI-TING HSU, CHING MING CHANG and JING-JIM OU

Anticancer Research February 2026, 46 (2) 797-810; DOI: https://doi.org/10.21873/anticanres.17988
You have access
Magnolol Suppresses ERK/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma
CHI-HUAN LI, MING-CHOU KU, KUN-CHING LEE, PO-FU YUEH, FEI-TING HSU, RONG-FONG LIN, CHUNG-CHI YANG, WEI-CHUN WANG, JIANN-HWA CHEN, LI-CHO HSU and YUAN-HAO LEE

Anticancer Research September 2022, 42 (9) 4403-4410; DOI: https://doi.org/10.21873/anticanres.15940
You have access
Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib
CHE-JUI YANG, MENG-HSUAN WU, JAI-JEN TSAI, FEI-TING HSU, TE-CHUN HSIA, KUO-CHING LIU and YU-CHENG KUO

Anticancer Research May 2022, 42 (5) 2495-2505; DOI: https://doi.org/10.21873/anticanres.15728
You have access
20(S)-Ginsenoside Rh2 Suppresses Oral Cancer Cell Growth by Inhibiting the Src-Raf-ERK Signaling Pathway
HAIBO ZHANG, JUNKOO YI, EUNGYUNG KIM, YEONSIK CHOO, HUANG HAI, KIRIM KIM, EUN-KYONG KIM, ZAEYOUNG RYOO and MYOUNGOK KIM

Anticancer Research January 2021, 41 (1) 227-235; DOI: https://doi.org/10.21873/anticanres.14769
You have access
Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidine
NNE E. UKO, OSMAN F. GÜNER, J. PHILLIP BOWEN and DIANE F. MATESIC

Anticancer Research October 2019, 39 (10) 5329-5338; DOI: https://doi.org/10.21873/anticanres.13725
You have access
Suppression of ERK/NF-κB Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression In Vivo
YEN-JU LEE, JING-GUNG CHUNG, YI-TING CHIEN, SONG-SHEI LIN and FEI-TING HSU

Anticancer Research July 2019, 39 (7) 3669-3675; DOI: https://doi.org/10.21873/anticanres.13515
You have access
Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo
JAI-JEN TSAI, FEI-TING HSU, PO-JUNG PAN, CHIA-WEN CHEN and YU-CHENG KUO

Anticancer Research April 2018, 38 (4) 2119-2125;
You have access
Inhibition of Galectin-1 Sensitizes HRAS-driven Tumor Growth to Rapamycin Treatment
JAMES V. MICHAEL, JEREMY G.T. WURTZEL and LAWRENCE E. GOLDFINGER

Anticancer Research October 2016, 36 (10) 5053-5061;
You have access
Polyphosphate Derived from Lactobacillus brevis Inhibits Colon Cancer Progression Through Induction of Cell Apoptosis
AKI SAKATANI, MIKIHIRO FUJIYA, NOBUHIRO UENO, SHIN KASHIMA, JUNPEI SASAJIMA, KENTARO MORIICHI, KATSUYA IKUTA, HIROKI TANABE and YUTAKA KOHGO

Anticancer Research February 2016, 36 (2) 591-598;

Main menu

User menu

Search

ERK

Pages